TITRATE Trademark

Trademark Overview

On Thursday, July 17, 2008, a trademark application was filed for TITRATE with the United States Patent and Trademark Office. The USPTO has given the TITRATE trademark a serial number of 79057962. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, July 17, 2018. This trademark is owned by Novo Nordisk A/S. The TITRATE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials and studies to explore the effect of two different blood glucose targets and to affect glucose control in patients with type 2 diabetes using insulin detemir once daily in combination with agents for oral administration
titrate

General Information

Serial Number79057962
Word MarkTITRATE
Filing DateThursday, July 17, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, July 17, 2018
Registration Number3587471
Registration DateTuesday, March 10, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 23, 2008

Trademark Statements

Goods and ServicesMedical and scientific research, namely, conducting clinical trials and studies to explore the effect of two different blood glucose targets and to affect glucose control in patients with type 2 diabetes using insulin detemir once daily in combination with agents for oral administration

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 16, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovo Nordisk A/S
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDK
Party NameNovo Nordisk A/S
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDK
Party NameNovo Nordisk A/S
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDK

Trademark Events

Event DateEvent Description
Friday, February 15, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, February 15, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, April 14, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, June 21, 2016TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, June 21, 2016INVALIDATION PROCESSED
Thursday, June 16, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 16, 2015CANCELLED SECTION 71
Sunday, January 13, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, June 29, 2009FINAL DISPOSITION NOTICE SENT TO IB
Monday, June 29, 2009FINAL DISPOSITION PROCESSED
Thursday, June 11, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 10, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, December 23, 2008PUBLISHED FOR OPPOSITION
Wednesday, December 3, 2008NOTICE OF PUBLICATION
Friday, November 21, 2008REFUSAL PROCESSED BY IB
Tuesday, November 18, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 18, 2008ASSIGNED TO LIE
Wednesday, November 12, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 11, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 11, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 11, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 29, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 29, 2008REFUSAL PROCESSED BY MPU
Wednesday, October 29, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 28, 2008NON-FINAL ACTION WRITTEN
Monday, October 27, 2008ASSIGNED TO EXAMINER
Friday, September 26, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, September 25, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

titrate glucose using insulin diabetes type patients detemir once oral administration